Cannabis has moved from the margins of sport into the mainstream.
What was once avoided in locker rooms is now openly discussed as part of recovery strategies. CBD oils, topicals, and cannabis-derived products are increasingly used by athletes attempting to manage pain, improve sleep, and accelerate recovery.
This shift reflects a persistent gap in performance medicine: athletes continue to deal with unresolved pain, disrupted sleep, and incomplete recovery despite advances in training and rehabilitation.
The question is no longer whether cannabinoids are being used. The question is whether they work—and where they fit.
Photo by RUN 4 FFWPU: pexels.com
Why Athletes Are Using CBD
Recent data suggests that approximately 30–40% of athletes report using CBD, primarily for:
- Pain management
- Sleep improvement
- Stress reduction
This trend is largely driven by the need for alternatives to traditional pharmacologic approaches, particularly opioids and NSAIDs, which carry long-term risks.
Cannabinoids are being adopted as a perceived lower-risk option—but perception and clinical reality are not always aligned.
Biological Rationale
Cannabinoids interact with the endocannabinoid system (ECS), a regulatory network involved in:
- Pain signaling
- Immune response
- Mood regulation
- Sleep cycles
CBD does not directly bind to cannabinoid receptors in the same way THC does. Instead, it modulates multiple pathways, including serotonergic and vanilloid systems, which influence pain perception, inflammation, and stress response.¹
This creates a plausible biological basis for its use in recovery.
But plausibility is not the same as proven effect.
Photo by Kindel Media:pexels.com
Pain: The Most Consistent Use Case
Cannabinoids may influence pain through both peripheral and central mechanisms, including interaction with TRPV1 receptors and serotonin pathways.¹
Athletes frequently report reductions in perceived pain and soreness.
Clinical evidence supports modest analgesic effects in chronic pain populations, but data specific to athletes remains limited.²
Importantly, reducing pain does not necessarily equate to improved recovery—it may simply alter perception.
Inflammation and Recovery
CBD has demonstrated anti-inflammatory properties in preclinical and early human studies, including:
- Reduction in pro-inflammatory cytokines
- Modulation of immune signaling
These effects are relevant, as chronic low-grade inflammation contributes to delayed recovery and neuromuscular inefficiency.³
However, controlled studies in athletic populations have not consistently shown improvements in:
- Muscle recovery
- Strength restoration
- Performance output
A recent systematic review concluded that CBD does not reliably enhance recovery metrics in trained individuals.⁴
Photo by KATRIN BOLOVTSOVA: .pexels.com
Sleep: A More Compelling Application
Sleep is one of the most critical—and most disrupted—components of athletic recovery.
CBD has been associated with:
- Reduced sleep latency
- Improved sleep continuity
- Decreased anxiety-related sleep disruption⁵
This may represent its most practical application in sports.
Improved sleep directly impacts:
- Hormonal recovery
- Cognitive function
- Motor learning
However, responses vary significantly based on dosing, timing, and individual physiology.
THC: Not the Same Conversation
CBD and THC are often grouped, but they have fundamentally different effects.
THC is psychoactive and has been associated with:
- Impaired reaction time
- Reduced coordination
- Altered cardiovascular response⁶
There is no evidence that THC enhances performance. In some cases, it may impair it.⁷
This distinction is critical when evaluating cannabis use in sport.
The Evidence Gap
The current state of cannabinoid research in athletics is defined by:
- Strong theoretical mechanisms
- High anecdotal use
- Limited high-quality clinical data
Systematic reviews consistently conclude that evidence is insufficient to support cannabinoids as performance-enhancing or recovery-accelerating agents.⁴,⁸
At the same time, there is moderate support for their role in:
- Pain modulation
- Sleep regulation
- Anxiety reduction
This discrepancy requires careful interpretation.
Photo by GB The Green Brand:pexels.com
Where CBD Fits—and Where It Doesn’t
CBD should not be viewed as a primary performance intervention.
It does not improve:
- Movement mechanics
- Neurological efficiency
- Structural stability
Instead, it functions as a modulator, influencing secondary variables such as pain, sleep, and stress.
This distinction is essential.
Used appropriately, CBD may support recovery.
Used in place of proper diagnosis and treatment, it may delay it.
The Risk of Misapplication
The primary risk is not the compound itself—it is how it is used.
If CBD is used to:
- Mask pain
- Avoid addressing underlying dysfunction
- Delay diagnostic evaluation
It may:
- Reinforce compensatory movement patterns
- Increase injury risk
- Prolong recovery timelines
This is particularly relevant in high-impact sports, where structural and neurological factors are often the true drivers of dysfunction.
What Comes Next
For cannabinoids to be properly integrated into sports medicine, several gaps must be addressed:
- Standardized dosing protocols
- Athlete-specific clinical trials
- Product consistency and regulation
- Integration with objective performance data
The future is not cannabinoids alone, it is cannabinoids within a structured, data-driven recovery model.
Conclusion
CBD and cannabis are not trends—they are emerging tools in the recovery landscape.
But current evidence supports a measured position:
CBD may provide benefit in pain, sleep, and stress modulation, but it is not a primary driver of performance or recovery.
Its role is adjunctive.
Understanding that distinction is what determines whether it helps—or hinders—long-term performance.
Key Takeaways
- CBD use is widespread: ~30–40% of athletes report using it, primarily for pain and sleep.
- Biology supports potential: CBD interacts with the endocannabinoid system, influencing inflammation, pain, and stress.
- Evidence is limited: Current research does not support CBD as a performance enhancer or recovery accelerator.
- Best-supported use case: Sleep and anxiety regulation show the most consistent benefit.
- THC is different: It may impair coordination and reaction time; no evidence supports a performance benefit.
- CBD is not foundational: It does not correct structural, neurological, or movement deficits.
- Primary risk is misuse: Masking pain without diagnosis may worsen long-term outcomes.
- Clinical position: CBD is an adjunct—useful in context, ineffective in iTo solation.
Dr. Robert Pomahac is a spine specialist, researcher, and founder of Modern Health U (MHU), a platform focused on advanced diagnostics, biomechanics, and human performance. His work integrates structural, neurological, and functional data to improve recovery, injury evaluation, and performance outcomes. For more information contact him at his website https://modernhealthu.com
References
- Ibeas Bih C, Chen T, Nunn AVW, et al. Molecular targets of cannabidiol. Neurotherapeutics. 2015;12(4):699-730.
- Häuser W, Petzke F, Fitzcharles MA. Cannabis-based medicines for chronic pain. Eur J Pain. 2018;22(3):455-470.
- Atalay S, Jarocka-Karpowicz I, Skrzydlewska E. Cannabidiol and inflammation. Front Pharmacol. 2023;14:1210202.
- Burr JF, Cheung CP, Kasper AM, et al. Cannabidiol and sports performance. Sports Med. 2024;54(2):245-258.
- Shannon S, Lewis N, Lee H, Hughes S. Cannabidiol in sleep and anxiety. Perm J. 2019;23:18-041.
- Pesta DH, Angadi SS, Burtscher M, Roberts CK. Cannabis and exercise performance. Sports Med. 2013;43(11):1035-1045.
- Kennedy MC. Cannabis and sport performance. J Clin Sport Psychol. 2017;11(3):203-211.
- McCartney D, Benson MJ, Desbrow B, et al. Cannabidiol and sports performance: a review. Sports Med. 2020;50(4):633-646.
